BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3150541)

  • 1. The refined crystal structure of subtilisin Carlsberg at 2.5 A resolution.
    Neidhart DJ; Petsko GA
    Protein Eng; 1988 Oct; 2(4):271-6. PubMed ID: 3150541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.
    Bode W; Papamokos E; Musil D
    Eur J Biochem; 1987 Aug; 166(3):673-92. PubMed ID: 3301348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic studies of the inhibitory effects of propeptides subtilisin BPN' and Carlsberg to bacterial serine proteases.
    Huang HW; Chen WC; Wu CY; Yu HC; Lin WY; Chen ST; Wang KT
    Protein Eng; 1997 Oct; 10(10):1227-33. PubMed ID: 9488148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic specificities of BPN' and Carlsberg subtilisins. Mapping the aromatic binding site.
    Karasaki Y; Ohno M
    J Biochem; 1978 Sep; 84(3):531-8. PubMed ID: 102640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the alkaline proteinase Savinase from Bacillus lentus at 1.4 A resolution.
    Betzel C; Klupsch S; Papendorf G; Hastrup S; Branner S; Wilson KS
    J Mol Biol; 1992 Jan; 223(2):427-45. PubMed ID: 1738156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution.
    Takeuchi Y; Satow Y; Nakamura KT; Mitsui Y
    J Mol Biol; 1991 Sep; 221(1):309-25. PubMed ID: 1920411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics refinement of a thermitase-eglin-c complex at 1.98 A resolution and comparison of two crystal forms that differ in calcium content.
    Gros P; Betzel C; Dauter Z; Wilson KS; Hol WG
    J Mol Biol; 1989 Nov; 210(2):347-67. PubMed ID: 2689655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal and molecular structure of the inhibitor eglin from leeches in complex with subtilisin Carlsberg.
    McPhalen CA; Schnebli HP; James MN
    FEBS Lett; 1985 Aug; 188(1):55-8. PubMed ID: 3926539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of calcium-independent subtilisin BPN' with restored thermal stability folded without the prodomain.
    Almog O; Gallagher T; Tordova M; Hoskins J; Bryan P; Gilliland GL
    Proteins; 1998 Apr; 31(1):21-32. PubMed ID: 9552156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the complete amino-acid sequence of subtilisin DY and its comparison with the primary structures of the subtilisins BPN', Carlsberg and amylosacchariticus.
    Nedkov P; Oberthür W; Braunitzer G
    Biol Chem Hoppe Seyler; 1985 Apr; 366(4):421-30. PubMed ID: 3927935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo.
    McPhalen CA; James MN
    Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of subtilisin DY, a random mutant of subtilisin Carlsberg.
    Eschenburg S; Genov N; Peters K; Fittkau S; Stoeva S; Wilson KS; Betzel C
    Eur J Biochem; 1998 Oct; 257(2):309-18. PubMed ID: 9826175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
    Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallographic investigations of subtilisin BPN' mutants engineered for studying thermal stability.
    Oliver JD; Rydel TJ; Strickland LC
    Adv Exp Med Biol; 1996; 379():191-201. PubMed ID: 8796324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of thermitase at 1.4 A resolution.
    Teplyakov AV; Kuranova IP; Harutyunyan EH; Vainshtein BK; Frömmel C; Höhne WE; Wilson KS
    J Mol Biol; 1990 Jul; 214(1):261-79. PubMed ID: 2196375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QSAR analysis of the subtilisin hydrolysis of X-phenyl hippurates. II. A study of subtilisin BPN'.
    Carotti A; Raguseo C; Klein TE; Langridge R; Hansch C
    Chem Biol Interact; 1988; 67(3-4):171-84. PubMed ID: 3056624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crystal structure of an oxidatively stable subtilisin-like alkaline serine protease, KP-43, with a C-terminal beta-barrel domain.
    Nonaka T; Fujihashi M; Kita A; Saeki K; Ito S; Horikoshi K; Miki K
    J Biol Chem; 2004 Nov; 279(45):47344-51. PubMed ID: 15342641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular enzymes: gene regulation and structure function relationship studies.
    Jarnagin AS; Ferrari E
    Biotechnology; 1992; 22():189-217. PubMed ID: 1504587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.